Jenapharm

Jenapharm is a leading German pharmaceutical company specializing in hormonal preparations for women's and men's health. Founded in 1950 and headquartered in Jena, the company became a subsidiary of Schering AG in 1996 and subsequently part of Bayer following the 2006 merger. It is the market leader in Germany for oral contraceptives, with a portfolio featuring prominent brands such as Valette, Maxim, and Qlaira. Beyond contraception, Jenapharm provides specialized treatments for menopause, endometriosis, and androgen deficiency. The company maintains a strong regional presence in Thuringia and remains a key commercial entity within Bayer's pharmaceutical division.